Vijay U. Rao MD, PhD , Anita Deswal MD, MPH , Daniel Lenihan MD , Susan Dent MD , Teresa Lopez-Fernandez MD , Alexander R. Lyon MD , Ana Barac MD, PhD , Nicolas Palaskas MD , Ming Hui Chen MD, MMSc , Hector R. Villarraga MD , Diego Sadler MD , Courtney M. Campbell MD, PhD , Kerry Skurka RN, BSN , Matt J. Wagner , Matthias Totzeck MD, PhD , Kathryn J. Ruddy MD, MPH , Paul Heidenreich MD , Randal Thomas MD , Daniel Addison MD , Sarju Ganatra MD , Joerg Herrmann MD
{"title":"心脏肿瘤学的护理质量测量","authors":"Vijay U. Rao MD, PhD , Anita Deswal MD, MPH , Daniel Lenihan MD , Susan Dent MD , Teresa Lopez-Fernandez MD , Alexander R. Lyon MD , Ana Barac MD, PhD , Nicolas Palaskas MD , Ming Hui Chen MD, MMSc , Hector R. Villarraga MD , Diego Sadler MD , Courtney M. Campbell MD, PhD , Kerry Skurka RN, BSN , Matt J. Wagner , Matthias Totzeck MD, PhD , Kathryn J. Ruddy MD, MPH , Paul Heidenreich MD , Randal Thomas MD , Daniel Addison MD , Sarju Ganatra MD , Joerg Herrmann MD","doi":"10.1016/j.jaccao.2024.11.003","DOIUrl":null,"url":null,"abstract":"<div><div>This document serves as a perspective on quality assessments in the discipline of cardio-oncology. We aim to define the current landscape, identify needs for quality and outcome improvements, and propose a roadmap for establishing viable metrics to improve patient care. Specifically, this document: 1) addresses the current lack of measurable high-quality metrics in cardio-oncology and their implications; 2) highlights needs and topic-specific barriers; 3) illustrates the process and application of a measurable quality metric; and 4) provides a framework to demonstrate measurable value for the growing population of patients with cancer and cardiovascular diseases.</div></div>","PeriodicalId":48499,"journal":{"name":"Jacc: Cardiooncology","volume":"7 3","pages":"Pages 191-202"},"PeriodicalIF":12.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Quality-of-Care Measures for Cardio-Oncology\",\"authors\":\"Vijay U. Rao MD, PhD , Anita Deswal MD, MPH , Daniel Lenihan MD , Susan Dent MD , Teresa Lopez-Fernandez MD , Alexander R. Lyon MD , Ana Barac MD, PhD , Nicolas Palaskas MD , Ming Hui Chen MD, MMSc , Hector R. Villarraga MD , Diego Sadler MD , Courtney M. Campbell MD, PhD , Kerry Skurka RN, BSN , Matt J. Wagner , Matthias Totzeck MD, PhD , Kathryn J. Ruddy MD, MPH , Paul Heidenreich MD , Randal Thomas MD , Daniel Addison MD , Sarju Ganatra MD , Joerg Herrmann MD\",\"doi\":\"10.1016/j.jaccao.2024.11.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>This document serves as a perspective on quality assessments in the discipline of cardio-oncology. We aim to define the current landscape, identify needs for quality and outcome improvements, and propose a roadmap for establishing viable metrics to improve patient care. Specifically, this document: 1) addresses the current lack of measurable high-quality metrics in cardio-oncology and their implications; 2) highlights needs and topic-specific barriers; 3) illustrates the process and application of a measurable quality metric; and 4) provides a framework to demonstrate measurable value for the growing population of patients with cancer and cardiovascular diseases.</div></div>\",\"PeriodicalId\":48499,\"journal\":{\"name\":\"Jacc: Cardiooncology\",\"volume\":\"7 3\",\"pages\":\"Pages 191-202\"},\"PeriodicalIF\":12.0000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jacc: Cardiooncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666087324004150\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jacc: Cardiooncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666087324004150","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
This document serves as a perspective on quality assessments in the discipline of cardio-oncology. We aim to define the current landscape, identify needs for quality and outcome improvements, and propose a roadmap for establishing viable metrics to improve patient care. Specifically, this document: 1) addresses the current lack of measurable high-quality metrics in cardio-oncology and their implications; 2) highlights needs and topic-specific barriers; 3) illustrates the process and application of a measurable quality metric; and 4) provides a framework to demonstrate measurable value for the growing population of patients with cancer and cardiovascular diseases.
期刊介绍:
JACC: CardioOncology is a specialized journal that belongs to the esteemed Journal of the American College of Cardiology (JACC) family. Its purpose is to enhance cardiovascular care for cancer patients by publishing high-quality, innovative scientific research and sharing evidence-based knowledge.
The journal aims to revolutionize the field of cardio-oncology and actively involve and educate professionals in both cardiovascular and oncology fields. It covers a wide range of topics including pre-clinical, translational, and clinical research, as well as best practices in cardio-oncology. Key areas of focus include understanding disease mechanisms, utilizing in vitro and in vivo models, exploring novel and traditional therapeutics (across Phase I-IV trials), studying epidemiology, employing precision medicine, and investigating primary and secondary prevention.
Amyloidosis, cardiovascular risk factors, heart failure, and vascular disease are some examples of the disease states that are of particular interest to the journal. However, it welcomes research on other relevant conditions as well.